Wehling, Martin
Weindrich, Johannes
Weiss, Christel
Heser, Kathrin
Pabst, Alexander
Luppa, Melanie
Bickel, Horst
Weyerer, Siegfried
Pentzek, Michael
König, Hans-Helmut
Lühmann, Dagmar
van der Leeden, Carolin
Scherer, Martin
Riedel-Heller, Steffi G.
Wagner, Michael
Pazan, Farhad
Funding for this research was provided by:
Medizinische Fakultät Mannheim der Universität Heidelberg
Article History
Accepted: 6 May 2024
First Online: 7 June 2024
Declarations
:
: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The AgeCoDe study was funded by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung/BMBF).
: M. Wehling was employed by AstraZeneca R&D, Mölndal, as director of discovery medicine (translational medicine) from 2003 to 2006, while on sabbatical leave from his professorship at the University of Heidelberg. Since returning to this position in January 2007, he has received lecturing and consulting fees from ASPEN, Bristol Myers, Bayer, Berlin-Chemie, LEO, Mundipharma, Novartis, Pfizer, Polyphor, Helsinn, Allecra, Santhera, Allergan, Novo-Nordisk, Lilly, AstraZeneca, Roche, Heel, Sanofi-Aventis, Shire, andDaichii-Sankyo. He will receive licence fees from Optimedis if the algorithms generate revenue. All other authors declared that they have no conflict of interest.
: The data used in this study can only be provided to other researchers upon submission of a written request and evaluation by the study group.
: Conceptualization: Martin Wehling, Farhad Pazan. Data curation: Martin Wehling, Johannes Weindrich, Christel Weiss, Kathrin Heser, Alexander Pabst, Melanie Luppa, Horst Bickel, Siegfried Weyerer, Michael Pentzek, Hans-Helmut König, Dagmar Lühmann, Carolin van der Leeden, Martin Scherer, Steffi G. Riedel-Heller, Michael Wagner, Farhad Pazan. Formal analysis: Farhad Pazan, Martin Wehling, Johannes Weindrich, Christel Weiss. Funding acquisition: Melanie Luppa, Michael Pentzek, Horst Bickel, Siegfried Weyerer, Hans-Helmut König, Kathrin Heser, Martin Scherer, Steffi Riedel-Heller, Michael Wagner. Investigation: Martin Wehling, Johannes Weindrich, Christel Weiss, Kathrin Heser, Alexander Pabst, Melanie Luppa, Horst Bickel, Siegfried Weyerer, Michael Pentzek, Hans-Helmut König, Dagmar Lühmann, Carolin van der Leeden, Martin Scherer, Steffi G. Riedel-Heller, Michael Wagner, Farhad Pazan Methodology: Farhad Pazan, Johannes Weindrich, Christel Weiss, Martin Wehling. Project administration: Farhad Pazan, Martin Wehling. Resources: Martin Wehling, Johannes Weindrich, Christel Weiss, Kathrin Heser, Alexander Pabst, Melanie Luppa, Horst Bickel, Siegfried Weyerer, Michael Pentzek, Hans-Helmut König, Dagmar Lühmann, Carolin van der Leeden, Martin Scherer, Steffi G. Riedel-Heller, Michael Wagner, Farhad Pazan. Software: OptiMedis. Supervision: Farhad Pazan, Martin Wehling. Validation: N/A. Visualization: Farhad Pazan, Johannes Weindrich, Martin Wehling. Writing—original draft: Martin Wehling, Johannes Weindrich, Christel Weiss, Kathrin Heser, Alexander Pabst, Melanie Luppa, Horst Bickel, Siegfried Weyerer, Michael Pentzek, Hans-Helmut König, Dagmar Lühmann, Carolin van der Leeden, Martin Scherer, Steffi G. Riedel-Heller, Michael Wagner, Farhad Pazan. Writing—review and editing: Martin Wehling, Johannes Weindrich, Christel Weiss, Kathrin Heser, Alexander Pabst, Melanie Luppa, Horst Bickel, Siegfried Weyerer, Michael Pentzek, Hans-Helmut König, Dagmar Lühmann, Carolin van der Leeden, Martin Scherer, Steffi G. Riedel-Heller, Michael Wagner, Farhad Pazan.
: These studies were approved by the ethics committees of all the participating centers (Bonn, Düsseldorf, Hamburg, Leipzig, Mannheim and Munich) and were conducted in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. In addition, this study was covered by the ethics approvals which were previously received (reference number: 2007-253E-MA), and it was recently evaluated and approved by the ethics committee in Mannheim (reference number: TEMP558252-AF 11).
: Not applicable.
: Not available.
: Not applicable.